David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Metallus
MTUS
$776M
| $15M | 0.01% |
1,274,194
+271,285
| +27% | +$2.03M |
|
|
YELL
1027
DELISTED
Yellow Corporation Common Stock
YELL
| $15M | 0.01% |
1,703,332
+1,346,924
| +378% | +$8.69M |
|
1028
Huazhu Hotels Group
HTHT
$15B
| $15M | 0.01% |
272,557
-423,645
| -61% | -$22.7M |
|
|
NEWR
1029
DELISTED
New Relic, Inc.
NEWR
| $14.9M | 0.01% |
243,100
-71,862
| -23% | -$4.77M |
|
1030
PUT
Amgen
AMGN
$240B
| $14.9M | 0.01% |
60,000
+6,500
| +12% | +$1.55M |
|
|
CLR
1031
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $14.9M | 0.01% |
576,162
-428,309
| -43% | -$10M |
|
1032
PUT
Lam Research
LRCX
$388B
| $14.9M | 0.01% |
250,000
-891,000
| -78% | -$48.5M |
|
|
TGI
1033
DELISTED
Triumph Group
TGI
| $14.9M | 0.01% |
808,060
+297,833
| +58% | +$4.45M |
|
|
LCAHU
1034
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
| $14.8M | 0.01% |
+1,500,000
| New | +$14.9M |
|
|
IMGN
1035
DELISTED
Immunogen Inc
IMGN
| $14.8M | 0.01% |
1,831,244
+575,562
| +46% | +$4.7M |
|
1036
Nike
NKE
$60.5B
| $14.8M | 0.01% |
111,611
-852,120
| -88% | -$118M |
|
1037
Paycom
PAYC
$10.3B
| $14.7M | 0.01% |
39,847
+31,343
| +369% | +$12.4M |
|
1038
Ingersoll Rand
IR
$31B
| $14.7M | 0.01% |
299,040
+29,481
| +11% | +$1.36M |
|
1039
Churchill Downs
CHDN
$6.32B
| $14.7M | 0.01% |
129,168
+9,446
| +8% | +$1.04M |
|
|
DAY
1040
DELISTED
Dayforce
DAY
| $14.7M | 0.01% |
173,962
-124,469
| -42% | -$11.6M |
|
1041
CALL
MetLife
MET
$61.1B
| $14.6M | 0.01% |
240,300
+44,600
| +23% | +$2.46M |
|
1042
PUT
AutoZone
AZO
$49.1B
| $14.6M | 0.01% |
10,400
-45,200
| -81% | -$56M |
|
1043
AdvanSix
ASIX
$454M
| $14.5M | 0.01% |
541,980
-53,319
| -9% | -$1.36M |
|
|
EB
1044
DELISTED
Eventbrite
EB
| $14.5M | 0.01% |
655,117
+85,029
| +15% | +$1.71M |
|
1045
Envista
NVST
$4.39B
| $14.5M | 0.01% |
355,816
+8,242
| +2% | +$314K |
|
|
VTLE
1046
DELISTED
Vital Energy
VTLE
| $14.5M | 0.01% |
482,329
+68,507
| +17% | +$2.1M |
|
1047
SLM Corp
SLM
$4.95B
| $14.5M | 0.01% |
806,397
+795,599
| +7,368% | +$12.1M |
|
1048
CALL
Merck
MRK
$372B
| $14.5M | 0.01% |
196,605
-23,789
| -11% | -$1.75M |
|
|
APLS
1049
DELISTED
Apellis Pharmaceuticals
APLS
| $14.4M | 0.01% |
336,643
-77,419
| -19% | -$3.66M |
|
|
ZGNX
1050
DELISTED
Zogenix, Inc.
ZGNX
| $14.4M | 0.01% |
739,121
-469,509
| -39% | -$9.63M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.